{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:22:42Z","timestamp":1783027362399,"version":"3.54.6"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,13]],"date-time":"2026-12-13T00:00:00Z","timestamp":1797120000000},"content-version":"am","delay-in-days":315,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005188","name":"Tobacco-Related Disease Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ajo.2025.11.026","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T02:26:22Z","timestamp":1763691982000},"page":"385-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Proportion of Fast Progressors in the Central versus Global Visual Field Across Varying Glaucoma Severity Groups"],"prefix":"10.1016","volume":"282","author":[{"given":"Gopikasree","family":"Gunasegaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9375-4711","authenticated-orcid":false,"given":"Sasan","family":"Moghimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8312-6623","authenticated-orcid":false,"given":"Takashi","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Liebmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7489-089X","authenticated-orcid":false,"given":"Massimo A.","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5781-7682","authenticated-orcid":false,"given":"Christopher A.","family":"Girkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1143-5224","authenticated-orcid":false,"given":"Linda M.","family":"Zangwill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9553-3202","authenticated-orcid":false,"given":"Robert N.","family":"Weinreb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ajo.2025.11.026_bib0001","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.026_bib0002","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ophtha.2022.04.012","article-title":"Retinal nerve fiber layer optical texture analysis: involvement of the papillomacular bundle and papillofoveal bundle in early glaucoma","volume":"129","author":"Leung","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.11.026_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2012.08.003","article-title":"Glaucomatous damage of the macula","volume":"32","author":"Hood","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajo.2025.11.026_bib0004","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ajo.2018.01.001","article-title":"Baseline 24-2 central visual field damage is predictive of global progressive field loss","volume":"187","author":"Garg","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.026_bib0005","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/jamaophthalmol.2013.7656","article-title":"Prevalence and nature of early glaucomatous defects in the central 10 degrees of the visual field","volume":"132","author":"Traynis","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.026_bib0006","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ophtha.2015.10.046","article-title":"The impact of location of progressive visual field loss on longitudinal changes in quality of life of patients with glaucoma","volume":"123","author":"Abe","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.11.026_bib0007","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajo.2015.12.006","article-title":"The impact of visual field clusters on performance-based measures and vision-related quality of life in patients with glaucoma","volume":"163","author":"Sun","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.026_bib0008","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jamaophthalmol.2015.1478","article-title":"Prevalence, risk factors, and visual features of undiagnosed glaucoma: the singapore epidemiology of eye diseases study","volume":"133","author":"Chua","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.026_bib0009","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1167\/iovs.13-13006","article-title":"Examining visual field loss in patients in glaucoma clinics during their predicted remaining lifetime","volume":"55","author":"Saunders","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.026_bib0010","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/eye.2013.294","article-title":"Portsmouth visual field database: an audit of glaucoma progression","volume":"28","author":"Kirwan","year":"2014","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.026_bib0011","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ophtha.2023.01.008","article-title":"Fast Progressors in glaucoma: prevalence based on global and central visual field loss","volume":"130","author":"Jackson","year":"2023","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.026_bib0012","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1167\/iovs.14-14643","article-title":"Rates of glaucomatous visual field change in a large clinical population","volume":"55","author":"Chauhan","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.026_bib0013","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/tvst.11.2.16","article-title":"Rates of glaucoma progression derived from linear mixed models using varied random effect distributions","volume":"11","author":"Swaminathan","year":"2022","journal-title":"Transl Vis Sci Technol"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.026_bib0014","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1111\/aos.12788","article-title":"Progression of visual field in patients with primary open-angle glaucoma\u2014ProgF study 1","volume":"93","author":"Aptel","year":"2015","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.026_bib0015","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/eye.2015.161","article-title":"Are rates of vision loss in patients in English glaucoma clinics slowing down over time? Trends from a decade of data","volume":"29","author":"Boodhna","year":"2015","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ajo.2025.11.026_bib0016","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ajo.2017.06.003","article-title":"Risk factors for rapid glaucoma disease progression","volume":"180","author":"Chan","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.026_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2025.04.031","article-title":"Differential impact of central and global visual field progression on quality of life in glaucoma","author":"Gunasegaran","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.026_bib0018","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/archophthalmol.2009.187","article-title":"The African descent and glaucoma evaluation study (ADAGES): design and baseline data","volume":"127","author":"Sample","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.026_bib0019","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1167\/iovs.17-22390","article-title":"The effective dynamic ranges for glaucomatous visual field progression with standard automated perimetry and stimulus sizes III and V","volume":"59","author":"Wall","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2025.11.026_bib0020","series-title":"Clinical decisions in glaucoma","author":"Hodapp","year":"1993"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.026_bib0021","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.ophtha.2020.03.029","article-title":"visual field outcomes from the multicenter, randomized controlled laser in glaucoma and ocular hypertension trial (LiGHT)","volume":"127","author":"Wright","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.11.026_bib0022","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ajo.2020.05.019","article-title":"Rates of glaucomatous structural and functional change from a large clinical population: the duke glaucoma registry study","volume":"222","author":"Jammal","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.026_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127233","article-title":"Comparing glaucoma progression on 24-2 and 10-2 visual field examinations","volume":"10","author":"Rao","year":"2015","journal-title":"PLOS ONE"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.026_bib0024","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.ophtha.2017.04.021","article-title":"24-2 visual fields miss central defects shown on 10-2 tests in glaucoma suspects, ocular hypertensives, and early glaucoma","volume":"124","author":"De Moraes","year":"2017","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.026_bib0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/jamaophthalmol.2013.7656","article-title":"Prevalence and nature of early glaucomatous defects in the central 10\u00b0 of the visual field","volume":"132","author":"Traynis","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.026_bib0026","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ogla.2019.01.003","article-title":"Comparing 10-2 and 24-2 visual fields for detecting progressive central visual loss in glaucoma eyes with early central abnormalities","volume":"2","author":"Wu","year":"2019","journal-title":"Ophthalmol Glaucoma"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.026_bib0027","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.opx.0000134903.13651.8e","article-title":"Association of visual field loss and mobility performance in older adults: salisbury eye evaluation study","volume":"81","author":"Turano","year":"2004","journal-title":"Optom Vis Sci"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.026_bib0028","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0161-6420(82)34675-8","article-title":"Why do some people go blind from glaucoma?","volume":"89","author":"Grant","year":"1982","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.026_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136632","article-title":"Blindness and glaucoma: a multicenter data review from 7 academic eye clinics","volume":"10","author":"Rossetti","year":"2015","journal-title":"PLOS ONE"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.026_bib0030","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0002-9394(02)01403-4","article-title":"Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision","volume":"133","author":"Oliver","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.026_bib0031","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/s41598-020-80318-w","article-title":"Simultaneously performed combined 24-2 and 10-2 visual field tests in glaucoma","volume":"11","author":"Jung","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.026_bib0032","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcjo.2018.11.006","article-title":"Comparison of visual field tests in glaucoma patients with a central visual field defect","volume":"54","author":"Shin","year":"2019","journal-title":"Canadian J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.026_bib0033","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.ophtha.2013.04.027","article-title":"The cost of glaucoma care provided to Medicare beneficiaries from 2002 to 2009","volume":"120","author":"Quigley","year":"2013","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.026_bib0034","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00019053-200927030-00002","article-title":"Cost of illness of glaucoma","volume":"27","author":"Fiscella","year":"2009","journal-title":"PharmacoEconomics"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.026_bib0035","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.ophtha.2021.03.032","article-title":"The effect of transitioning from SITA standard to SITA faster on visual field performance","volume":"128","author":"Pham","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.11.026_bib0036","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ajo.2019.08.013","article-title":"Clinical evaluation of swedish interactive thresholding algorithm-faster compared with swedish interactive thresholding algorithm-standard in normal subjects, glaucoma suspects, and patients with glaucoma","volume":"208","author":"Phu","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.026_bib0037","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/archopht.124.10.1405","article-title":"Relative risk of progressive glaucomatous visual field loss in patients enrolled and not enrolled in a prospective longitudinal study","volume":"124","author":"Henson","year":"2006","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.026_bib0038","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.ophtha.2013.01.045","article-title":"Parafoveal Scotoma Progression in glaucoma: humphrey 10-2 versus 24-2 visual field analysis","volume":"120","author":"Park","year":"2013","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425006270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425006270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:58:53Z","timestamp":1783025933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425006270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":38,"alternative-id":["S0002939425006270"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.11.026","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proportion of Fast Progressors in the Central versus Global Visual Field Across Varying Glaucoma Severity Groups","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}